Jill Piens

Statistics

Publications

Citations

486

H-Index

Active since

2005

Affiliations

Mayo Clinic in Arizona(Current)

Jill Piens is an author at Mayo Clinic in Arizona specializing in toxicity management, pharmacokinetics of anticancer agents, and pharmacokinetics of anticancer drugs.

Publications per year

2005–2006

Publications

Phase I and Pharmacodynamic Study of the Oral MEK Inhibitor CI-1040 in Patients With Advanced Malignancies

Patricia LoRusso, Alex A. Adjei, Mary Varterasian et al. · Journal of Clinical Oncology · 2005 · 399 citations

Medicine, Oncology, Pharmacology +17

Phase 1 Trial of Flavopiridol Combined with Cisplatin or Carboplatin in Patients with Advanced Malignancies with the Assessment of Pharmacokinetic and Pharmacodynamic End Points

Keith C. Bible, Janet L. Lensing, Sacha A. Nelson et al. · Clinical Cancer Research · 2005 · 64 citations

Medicine, Oncology, Pharmacology +17

A phase I dose-escalation and pharmacokinetic (PK) study of a novel spectrum selective kinase inhibitor, XL647, in patients with advanced solid malignancies (ASM)

Heather A. Wakelee, Alex A. Adjei, Joanne Halsey et al. · Journal of Clinical Oncology · 2006 · 23 citations

Medicine, Oncology, Pharmacology +16

1–3 of 3